Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

February 15, 2026; Volume 23,Issue 2

Editorial

  • Open Access
    From concept to clinic: emerging paradigms and novel insights into liquid biopsy
    Wenjie Guo, Yang Liu, Haiying Dong, Xiang Li, Xu Guo, Haitao Guo, Kaixiang Zhou and Jinliang Xing
    Cancer Biology & Medicine February 2026, 23 (2) 155-161; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0830

Perspective

  • Open Access
    Pan-KRAS inhibition: unlocking broad-spectrum targeted therapy for KRAS-mutant cancers
    Juanjuan Feng, Xuanzheng Xiao, Zhengke Lian, Ao Zhang and Xiufeng Pang
    Cancer Biology & Medicine February 2026, 23 (2) 162-168; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0612

Reviews

  • Open Access
    Applying microfluidic technology to interpret the tumor immune microenvironment and cancer immunotherapy
    Xuhong Chen, Dongxian Tan, Shuaiting Liu, Ruolin Luo, Yang Liu, Miaomiao Zhang, Siqi Li and Jing Xu
    Cancer Biology & Medicine February 2026, 23 (2) 169-185; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0541
  • Open Access
    Targeting tumor-infiltrating regulatory T cells based on immunometabolism
    Na Li and Dexue Tian
    Cancer Biology & Medicine February 2026, 23 (2) 186-200; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0645
  • Open Access
    First-line immunotherapy for advanced HER2-negative gastric cancer: differences between Asian and non-Asian patients
    Chuanhua Zhao, Sisi Ye, Meng Chen, Jing Qian and Jianming Xu
    Cancer Biology & Medicine February 2026, 23 (2) 201-217; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0398

Consensus

  • Open Access
    Expert consensus on the detection and clinical application of tumor mutational burden
    Zhenying Guo, Chunwei Xu, Shirong Zhang, Yue Hao, Xiaotong Hu, Ming Zhao, Chan Xiang, Yingshi Piao, Pingli Sun, Xueping Xiang, Jing Zhao, Huanwen Wu, Weixing Li, Jinpu Yu, Jingping Yuan, Shuangshuang Wang, Cong Wang, Yun Gu, Bingjian Lv, Liping Zhang, Yueping Liu, Xiaobin Cui, Weizhong Gu, Yining Li, Wei Wang, Wenjun Yang, Weiguo Long, Jingjing Xiang, Hong Mou, Biao Liu, Huajuan Ruan, Yubin Wang, Yongjie Zhu, Feng Wang, Zhonghua Wang, Xiaomin Feng, Xing Liu, Peng Li, Min Deng, Bin Lian, Lili Mao, Qian Wang, Wenxian Wang, Zhengbo Song, Ziming Li, Wenzhao Zhong, Zhijie Wang, Shengxiang Ren, Wenfeng Fang, Yongchang Zhang, Jingjing Liu, Xiuyu Cai, Anwen Liu, Wen Li, Ping Zhan, Hongbing Liu, Tangfeng Lv, Liyun Miao, Lingfeng Min, Yu Chen, Yu Zhang, Feng Wang, Zhansheng Jiang, Gen Lin, Long Huang, Xingxiang Pu, Rongbo Lin, Weifeng Liu, Chuangzhou Rao, Dongqing Lv, Zongyang Yu, Peng Shen, Xiaoyan Li, Chuanhao Tang, Chengzhi Zhou, Junping Zhang, Junli Xue, Hui Guo, Qian Chu, Rui Meng, Jingxun Wu, Rui Zhang, Jin Zhou, Zhengfei Zhu, Yongheng Li, Hong Qiu, Fan Xia, Yuanyuan Lu, Xiaofeng Chen, Rui Ge, Enyong Dai, Yu Han, Jian Zhang, Yinghua Ji, Xianbin Liang, Hongmei Zhang, Xuelei Ma, Xuewen Liu, Yu Yao, Peng Luo, Weiwei Pan, Fei Pang, Fan Wu, Dejian Gu, Li Wang, Liping Wang, Youcai Zhu, Li Lin, Weiwen Li, Xinqing Lin, Jing Cai, Ling Xu, Jisheng Li, Xiaodong Jiao, Kainan Li, Jia Wei, Huijing Feng, Lin Wang, Yingying Du, Wang Yao, Xuefei Shi, Xiaomin Niu, Dongmei Yuan, Yanwen Yao, Yinbin Zhang, Binbin Song, Wenfeng Li, Jianfei Fu, Hong Wang, Mingxiang Ye, Dong Wang, Zhaofeng Wang, Qing Ji, Yuan Fang, Qing Wei, Zhen Wang, Bin Wan, Donglai Lv, Xiaofeng Li, Shengjie Yang, Jing Kang, Jiatao Zhang, Chao Zhang, Lin Shi, Yina Wang, Bihui Li, Zhang Zhang, Ke Wang, Zhefeng Liu, Nong Yang, Lin Wu, Xiaobing Chen, Gu Jin, Zhongwu Li, Miao Li, Guansong Wang, Jiandong Wang, Meiyu Fang, Yong Fang, Xiaojia Wang, Jing Chen, Yiping Zhang, Xixu Zhu, Yi Shen, Shenglin Ma, Biyun Wang, Lu Si, Yong Song, Yuanzhi Lu, Aijun Liu and Yuchen Han
    Cancer Biology & Medicine February 2026, 23 (2) 218-246; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0351

Letter

  • Open Access
    Identification of immune reconstitution and hematopoiesis restoration by scRNA-seq in bone marrow of multiple myeloma patients treated with high-dose melphalan following auto-HSCT
    Qian Li, Yaling Wang, Hongfeng Yuan, Qiaomei Cai, Lina Zhao, Li Lin, Shuang Gao, Lin Chen, Zhiying Zhang, Jing Ma, Su Liu, Zeng Cao, Haifeng Zhao, Yufei Wang, Shihui Li, Pan Lv, Huihui Zhang, Guowen Wang, Guang Yang, Xiaodong Zhang and Yafei Wang
    Cancer Biology & Medicine February 2026, 23 (2) 247-251; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0585

Original Articles

  • Open Access
    VDAC1 protein derived from extracellular vesicles promotes paclitaxel resistance in gastric cancer through autophagy and mitophagy
    Yanna Bi, Sisi Wei, Zhe Zhang, Yuqing Wang, Yang Wen, Hongquan Wang, Kexin Li, Cong Zhang, Yumin Wang, Lianmei Zhao and Guogui Sun
    Cancer Biology & Medicine February 2026, 23 (2) 252-275; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0360
  • Open Access
    BEX2 influences the MCL1-Hedgehog signaling axis to regulate the potential of stemness characterization in colorectal cancer
    Yucheng Qian, Jingsun Wei, Yuan Bian, Yinuo Tan, Yimin Fang, Liubo Chen, Kai Jiang, Dongliang Fu, Xiaoxu Ge, Tianyi Ling, Qian Xiao, Kefeng Ding and Yeting Hu
    Cancer Biology & Medicine February 2026, 23 (2) 276-293; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0120
  • Open Access
    Temporal radiomics for non-invasive preoperative prediction of pathologic complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer
    Sunyi Zheng, Shuo Wang, Ziwei Feng, Jing Liang, Jiaxin Liu, Xiaomeng Yang, Zhanshuo Zhang, Yuechen Cui, Jiping Xie, Shuxuan Fan, Jing Wang, Guoqing Liao, Haiyu Zhou, Zhaoxiang Ye, Jianyu Xiao, Lei Shi, Xiaonan Cui and Dongsheng Yue
    Cancer Biology & Medicine February 2026, 23 (2) 294-309; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0327
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 23 (2)
Cancer Biology & Medicine
Vol. 23, Issue 2
15 Feb 2026
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Editorial
  • Perspective
  • Reviews
  • Consensus
  • Letter
  • Original Articles

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire